312 767-4413 – info@kheprirenewal.com

What you need to know about the FDA’s warning to consumers about CBD and how Khepri Renewal is different.

The U.S. Food and Drug Administration recently published a revised consumer update about products containing cannabis, including CBD products, that has created a lot of confusion among consumers and the cannabis industry alike. 

At Khepri Renewal, we aim to provide our community with the information they need to make informed decisions about their health and well being. That’s why we wanted to share this information with you in response to the FDA’s consumer update and the warning letters it sent to 15 other CBD companies.

What does the FDA say about CBD? 

In its revised consumer update, the FDA acknowledges there is increasing public interest in using cannabis products, but cautions against it because it claims there are still many unanswered questions about the “science, safety and quality of products containing CBD.” While it is true there are a lot of unanswered questions about CBD, the reason for this lack of scientific study is that the FDA, the agency responsible for conducting these studies, has not yet chosen to commission comprehensive studies of CBD.

To date, the only study that the FDA has released on CBD products was for Epidiolex by GW Pharmaceuticals, which is a high dose prescription drug used to treat two rare forms of epilepsy. The review found that there may be side effects to using such a high dose (1,400 - 3,500 mg as compared to a consumer products dosage at 10-20 mg), including possible liver injury and adverse interactions with other prescription medications. However, the study led to the approval of Epidiolex, as the FDA determining that any risks from the medication were outweighed by the benefits for people living with these forms of epilepsy. 

Despite the success of Epidiolex, the FDA has not yet completed studies into lower dose CBD products for use in addressing other medical issues, nor have they studied it as a dietary supplement. 

What research do we have?

Research into the side effects of cannabis and CBD products is inconsistent, largely because there hasn’t been enough of it. Some studies suggest that cannabis use can lower male sperm counts, while other studies say the opposite. The FDA’s own research into Epidiolex suggested side effects, but they couldn’t determine whether those side effects were due to that drug or a result of the other medications that people suffering with the rare epilepsy conditions were taking at the same time. 

Additionally, the Epidiolex study was specifically researching a high dose medication. As Justin Singer, co-founder of CBD-infused supplement brand Caliper Foods, points out, “that’s like saying ‘drinking coffee is dangerous,’ when the data actually indicate drinking 70 cups of coffee is dangerous. As ever, the dose makes the poison.” 

Meanwhile, independent studies are showing that the endocannabinoid system is more important than previously thought - Scientific Reports discussed its importance to the male reproductive system in September 2019

The World Health Organization (WHO) and National Institute on Drug Abuse (NIDA) aren’t concerned with any health risks associated with consuming CBD products. And the UK’s National Health service just approved Epidiolex and Sativex for treatment of epilepsy and multiple sclerosis, respectively. 

We may soon have more answers, though, as the FDA announced this fall that they will be commissioning nine new studies into CBD products, committing some $3 million to the effort to better understand their benefits and potential risks. 

Khepri Renewal’s approach to CBD.

Khepri Renewal takes pride in our products, from harvest to bottle. Our products are CO2 extracted, which is the purest and cleanest method of extraction. All of our products are third party tested and we are fully transparent with our results. We have a quality control system and a third-party laboratory we work with that analyzes all of our hemp extracts and our final products for cannabinoid potency, heavy metals, bacterial and microbial life, mycotoxins and pesticides. 

It’s important for consumers to do their homework and consult with a healthcare provider before using CBD products. Tatum Drewes, the founder and CEO of Khepri Renewal is also available to do consultations. (Click here to schedule.) There are many other companies that are producing and marketing CBD products by making unsubstantiated claims about its healing properties. The FDA sent warning letters to 15 companies last month that unlawfully claimed to prevent, diagnose, mitigate, treat or cure serious diseases, such as cancer. 

Because of the lack of state and federal regulations on hemp harvesting and cannabis products, CBD products can significantly vary in quality by state. Some manufacturers aren’t getting their products tested before selling it, which means that it’s possible that the product you’re buying could contain illegal amounts of THC, or worse, they could contain harmful metals and other toxic chemicals. 

There are actually more than 113 active compounds in cannabis plants, which explains why people use it to treat different ailments. At Khepri Renewal, we produce a broad spectrum hemp extract, CBD rich oil, with other cannabis compounds present because our formula encourages the maximum benefits for the consumer. 

Leave a comment

Name .
Message .

Please note, comments must be approved before they are published